Covered recipient · General Payments record
VIPUL D SHARMA
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2019–2024
$1,599.92
- Reported across 32 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,128.41 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Medtronic, Inc. | $168.78 | 1 |
| Nevro Corp. | $154.19 | 2 |
| Saluda Medical Americas, Inc. | $153.52 | 2 |
| Abbott Laboratories | $153.48 | 4 |
| Vertos Medical, Inc. | $140.00 | 1 |
| EISAI INC. | $122.85 | 1 |
| Stryker Corporation | $105.71 | 1 |
| BOSTON SCIENTIFIC CORPORATION | $70.47 | 1 |
| SPR Therapeutics, Inc | $59.41 | 3 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $115.14 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125115916 | CMS |
| Abbott Laboratories | $7.27 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125115918 | CMS |
| Abbott Laboratories | $20.90 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125115920 | CMS |
| Abbott Laboratories | $10.17 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125115922 | CMS |
| Boston Scientific Corporation | $70.47 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092313607 | CMS |
| Eisai Inc. | $122.85 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110787677 | CMS |
| Medtronic, Inc. | $168.78 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119366167 | CMS |
| Nevro Corp. | $25.67 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130762485 | CMS |
| Nevro Corp. | $128.52 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130762487 | CMS |
| Saluda Medical Americas, Inc. | $17.71 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1093671980 | CMS |
| Saluda Medical Americas, Inc. | $135.81 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1093675574 | CMS |
| SPR Therapeutics, Inc | $20.73 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104939845 | CMS |
| SPR Therapeutics, Inc | $19.58 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104941913 | CMS |
| SPR Therapeutics, Inc | $19.10 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104946555 | CMS |
| Stryker Corporation | $105.71 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144314397 | CMS |
| Vertos Medical, Inc. | $140.00 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133348417 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2021, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.